首页 | 本学科首页   官方微博 | 高级检索  
     

益眼明对青光眼视神经的保护作用
引用本文:王燕,邱波,张彩霞,欧扬,庞龙,李振萍,王旸. 益眼明对青光眼视神经的保护作用[J]. 眼科研究, 2010, 28(11): 1087-1090. DOI: 10.3969/j.issn.1003-0808.2010.11.019
作者姓名:王燕  邱波  张彩霞  欧扬  庞龙  李振萍  王旸
作者单位:广东省中医院眼科,广州,510120
摘    要:
目的探讨益眼明口服液对眼压已控制的青光眼患者视神经的保护作用。方法选择有视野缺损、眼压控制在≤18mmHg的原发性开角型青光眼患者52例101眼,随机分为试验组27例53眼和对照组25例48眼。对照组仅用噻吗心胺滴眼液点眼,试验组同时应用噻吗心胺滴眼液点眼及益眼明口服液每日3次口服,连续用药12周;观察用药前后视力、眼底的变化,分别于用药后4、8、12周检测视野平均敏感度(MS)、平均缺损值(MD)和丢失方差(LV)等指标,并与其术前值进行比较。结果用药前后各时间点试验组和对照组视力及眼底均未见明显改变。试验组用药4周后患者视野MS值明显高于用药前,差异有统计学意义(t=4.009,P=0.000);MD值明显低于用药前,差异有统计学意义(t=-2.587,P=0.013)。用药后8周,患者视野MS值明显高于用药前值,差异有统计学意义(t=8.848,P=0.000);MD和LV值明显下降,差异均有统计学意义(t=-3.874,P=0.000;t=-2.868,P=0.006)。试验组用药12周后,MS值的升高、MD与LV的下降与用药前比较差异均有统计学意义(t=5.086,P=0.000;t=-2.580,P=0.013;t=-2.765,P=0.008)。结论益眼明口服液对原发性开角型青光眼患者的视神经有一定程度的保护作用。

关 键 词:中药/益眼明口服液  原发性青光眼  视神经

Neuro-protective effects of yiyanming solution on visual function of glaucoma patient
WANG Yan,QIU Bo,ZHANG Cai-xia,OU Yang,PANG Long,LI Zhen-ping,WANG Yang. Neuro-protective effects of yiyanming solution on visual function of glaucoma patient[J]. Chinese Ophthalmic Research, 2010, 28(11): 1087-1090. DOI: 10.3969/j.issn.1003-0808.2010.11.019
Authors:WANG Yan  QIU Bo  ZHANG Cai-xia  OU Yang  PANG Long  LI Zhen-ping  WANG Yang
Affiliation:WANG Yan,QIU Bo,ZHANG Cai-xia,OU Yang,PANG Long,LI Zhen-ping,WANG Yang.Department of Ophthalmology,Guangdong Hospital of Traditional Chinese Medicine,Guangzhou 510120,China
Abstract:
Background Loss of retinal ganglion cells(RGCs)is a dominant feature of optic nerve in glaucoma.Our previous study showed that traditional Chinese herbs have a neuoprotective effect on RGCs.ObjectiveThis study was to evaluate the protective effect of yiyanming on optic nerve in glaucoma patient after controlled intraocular pressure(IOP).Methods Fifty-two patients(101 eyes)suffered from primary open-angle glaucoma with visual field defect and IOP less than 18mmHg were enrolled in this survey.The patients were randomly assigned to the therapeutic group(n=53)and the control group(n=48).Yiyanming solution 10 mL was administered orally three times per day for 12 weeks associated with the topical administration of in therapeutic group,and only was topically administered in the control group.The therapeutic effects of Yiyanming solution were assessed before treatment and at the end of the first,second,third month after treatment respectively.The changes of visual acuity,fundus and the mean defect(MD),mean sensitivity(MS)and 1oss vafiance(LV)of perimetry were observed.Written informed consent was obtained from the patients at the initial of this trial.ResultsNo obvious changes were found in visual acuity and fundus in all patients after administration of Yiyanming in both groups.In the 4th week after treatment,the MS value was significantly elevated(t=4.009,P=0.000),but the MD value was declined(t=-2.587,P=0.013)in comparison with before treatment.In the 8th week after treatment,the MS value was considerably increased(t=4.009,P=0.000),but the MD and LV values were decreased(t=-3.874,P=0.000;t=-2.868,P=0.006)in comparison with before treatment in Yiyanming group.The rise of MS value,decline of MD and LV were statistically different after treatment versus before treatment(t=5.086,P=0.000;t=-2.580,P=0.013;t=-2.765,P=0.008)at the 12nd week in the therapeutic group.ConclusionYiyanming oral solution may have protective effect on visual function of primary glaucoma with controlable IOP in some extent.
Keywords:Chinese traditional medicine/yiyanming oral solution  primary glaucoma  optic nerve
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号